Search research articles
Contact Us
Filters
Showing results (161-170 of 196) with videos related to
Page
of 20
Sort By:
JHEP Reports : Innovation in Hepatology
|
January 6, 2026
<i>P</i> <i>NPLA3</i> and <i>TM6SF2</i> exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis
Sophie Gensluckner, Helle Lindholm Schnefeld, Jan Embacher, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
August 7, 2025
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLD
Nina Dominik, Larissa Nixdorf, Michael Schwarz, et al.
Scientific Reports
|
July 30, 2024
Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study
Larissa Nixdorf, Lukas Hartl, Stefanie Ströhl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver disease
Benedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
The American Journal of Gastroenterology
|
May 13, 2021
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Monica Pons, Salvador Augustin, Bernhard Scheiner, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
JHEP Reports : Innovation in Hepatology
|
January 19, 2026
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease
Georg Kramer, Benedikt Simbrunner, Mathias Jachs, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
The Lancet. Gastroenterology & Hepatology
|
September 13, 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study
Nikolaj Torp, Katrine Tholstrup Bech, Helle Lindholm Schnefeld, et al.
EMBO Reports
|
November 23, 2020
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis
Valentina C Sladky, Katja Knapp, Tamas G Szabo, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 196) with videos related to
Sort By:
Page
of 20
JHEP Reports : Innovation in Hepatology
|
January 6, 2026
<i>P</i> <i>NPLA3</i> and <i>TM6SF2</i> exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis
Sophie Gensluckner, Helle Lindholm Schnefeld, Jan Embacher, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
August 7, 2025
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLD
Nina Dominik, Larissa Nixdorf, Michael Schwarz, et al.
Scientific Reports
|
July 30, 2024
Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study
Larissa Nixdorf, Lukas Hartl, Stefanie Ströhl, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver disease
Benedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
The American Journal of Gastroenterology
|
May 13, 2021
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Monica Pons, Salvador Augustin, Bernhard Scheiner, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
JHEP Reports : Innovation in Hepatology
|
January 19, 2026
Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease
Georg Kramer, Benedikt Simbrunner, Mathias Jachs, et al.
Hepatology (Baltimore, Md.)
|
March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
The Lancet. Gastroenterology & Hepatology
|
September 13, 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study
Nikolaj Torp, Katrine Tholstrup Bech, Helle Lindholm Schnefeld, et al.
EMBO Reports
|
November 23, 2020
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis
Valentina C Sladky, Katja Knapp, Tamas G Szabo, et al.
Page
of 20